Catalyst Pharmaceuticals (CPRX) EBITDA Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 261.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 261.00 |
| Dec 31, 2025 | -496.00 |
| Sep 30, 2025 | 145.00 |
| Jun 30, 2025 | 234.00 |
| Mar 31, 2025 | 1,645.00 |
| Dec 31, 2024 | 797.00 |
| Sep 30, 2024 | 6,406.00 |
| Jun 30, 2024 | -468.00 |
| Mar 31, 2024 | -1,101.00 |
| Dec 31, 2023 | -1,040.00 |
| Sep 30, 2023 | -6,998.00 |
| Jun 30, 2023 | -338.00 |
| Mar 31, 2023 | 460.00 |
| Dec 31, 2022 | 1,783.00 |
| Sep 30, 2022 | 1,137.00 |
| Jun 30, 2022 | 779.00 |
| Mar 31, 2022 | 490.00 |
| Dec 31, 2021 | -1,292.00 |
| Sep 30, 2021 | -11,916.00 |
| Jun 30, 2021 | 77.00 |
| Mar 31, 2021 | -1,092.00 |
| Dec 31, 2020 | 1,071.00 |
| Sep 30, 2020 | 10,371.00 |
| Jun 30, 2020 | -536.00 |
| Mar 31, 2020 | 4,111.00 |
| Dec 31, 2019 | 292,107.00 |